Should You Buy Elicio Therapeutics Inc (ELTX) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast ELTX stock price to rise
2 Analyst Rating
Wall Street analysts forecast ELTX stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 10.610
Low
13
Averages
15.5
High
18
Current: 10.610
Low
13
Averages
15.5
High
18
Ladenburg
Buy
initiated
$20
AI Analysis
2026-04-15
Reason
Ladenburg
Price Target
$20
AI Analysis
2026-04-15
initiated
Buy
Reason
Ladenburg initiated coverage of Elicio Therapeutics with a Buy rating and $20 price target. The firm says the company is creating the new standard of care in minimal residual disease positive pancreatic cancer.
H.C. Wainwright
Buy
maintain
$13 -> $17
2026-03-13
Reason
H.C. Wainwright
Price Target
$13 -> $17
2026-03-13
maintain
Buy
Reason
H.C. Wainwright raised the firm's price target on Elicio Therapeutics to $17 from $13 and keeps a Buy rating on the shares. To reflect the data seen to date, the firm increased its probability of success for ELI-002 to 50% from 30%.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ELTX
